PMS18 - Budget impact analysis of knee osteoarthritis viscosupplementation treatment in Brazil
PMS18 - Budget impact analysis of knee osteoarthritis viscosupplementation treatment in Brazil
dc.contributor.author | Senna, k | |
dc.contributor.author | Silva, G | |
dc.contributor.author | Tura, BR | |
dc.date.accessioned | 2022-10-07T13:50:33Z | |
dc.date.available | 2022-10-07T13:50:33Z | |
dc.date.issued | 2018 | |
dc.description.abstract | Knee osteoarthritis is the most common form of joint disease and has been shown to be associated with aging. It affects 3.8% of the population, worldwide, and causes significant disability, impairing patient’s quality of life. Current treatment options are as follows: pharmacological, non-pharmacological and surgical. Viscosupplementation is a treatment with exogenous hyaluronic acid applied to the knees for symptom relief and postponing surgery. This study aims to estimate the budget impact of viscosupplementation treatment for knee osteoarthritis. | |
dc.identifier.citation | Senna KMS, Silva G, Tura BR. PMS18 - Budget impact analysis of knee osteoarthritis viscosupplementation treatment in Brazil. Value in Health.2018;21(suppl 3):S290. | |
dc.identifier.doi | DOI: 10.1016/j.jval.2018.09.1732 | |
dc.identifier.uri | https://dspace.inc.saude.gov.br/handle/123456789/323 | |
dc.language.iso | en | |
dc.publisher | Value in Health | |
dc.subject | Budget impact analysis | en |
dc.subject | Knee osteoarthritis | en |
dc.subject | Treatment | en |
dc.title | PMS18 - Budget impact analysis of knee osteoarthritis viscosupplementation treatment in Brazil | en |
dc.type | Presentation |
Arquivos
Original bundle
1 - 1 de 1
- Nome:
- Produção Técnica_Senna k, Silva G, Tura BR_2018.pdf
- Tamanho:
- 378.47 KB
- Formato:
- Adobe Portable Document Format
- Descrição:
License bundle
1 - 1 de 1
thumbnail.default.placeholder
- Nome:
- license.txt
- Tamanho:
- 1.71 KB
- Formato:
- Item-specific license agreed to upon submission
- Descrição: